STOCKS TELEGRAPH

Tag: PACB

  • Pacific Biosciences of California, Inc. (PACB) stock is losing during after-hours. Here’s why

    On February 15, 2022, the stock of Pacific Biosciences of California, Inc (PACB) closed the trading session at $11.38, gaining 3.64% from the previous trading session. The stock kept oscillating between $10.84 and $11.49. During the last check, the stock lost 12.04% to $10.01 in the after-hours. Pacific Biosciences announced the financial results for its fourth quarter of the fiscal year 2021. The company also filed for Form 8-K with the SEC to announce the quarterly results.

    PACB Financials

    On February 15, 2022, Pacific Biosciences announced the financial results for Q4 of FY21, which ended on December 31, 2021. The revenue of the company during Q4 of the fiscal year 2021 was $36.01 million against $27.1 million in Q4 of FY20. The revenue increased by 33% during the fourth quarter of FY21. Net loss for Q4 of FY21 was reported to be $69.3 million versus the net income of $74.9 million in the same quarter the previous year. Diluted loss per share was $0.31 as compared to the earnings per share of $0.37 in Q4 of FY20.

    News

    The company inaugurated the HiFiViral SARS-CoV-2 Kit that labs can use to recognize new SARS-CoV-2 variants and distinguish between all circulating variants. Pacific Biosciences also declared cooperation with Genomics England to utilize HiFi sequencing technology. PACB also collaborated with Berry Genomics to produce a sequencing instrument for the Chinese clinical market.

    CEO Remarks

    The CEO of Pacific Biosciences Inc, Christian Henry, said that their record fourth-quarter addresses the climax of the most ground-breaking year in PacBio history. He added that they produced new items and hit a significant improvement milestone for the future stages.

    Mr. Henry concluded that PacBio should proceed with this force into 2022. Pacific Biosciences should set the stage for sped-up development in the preceding years.

    About PACB

    Pacific Biosciences Inc is a biotechnology organization that creates and produces frameworks for gene sequencing and novel biological observations. The company is based in Menlo Park, California, United States of America (USA).

  • Early Morning Vibes: Check Out These 3 hot Stocks Right Now

    Early Morning Vibes: Check Out These 3 hot Stocks Right Now

    On February 10, American stock exchanges closed without significant changes. The S&P 500 index fell by a symbolic 0.03%, to 3910 points, the Dow Jones added 0.20%, the NASDAQ lost 0.25%. During the day, losses in the S&P 500 reached 0.6%, but its weakness was temporary. There were no new drivers of movement, but optimism about fiscal stimulus remained heightened. The cyclical consumer goods sector looked noticeably weaker than the market (-0.94%) due to Tesla shares, which fell 5.25%.

    Company news

    Twitter (TWTR: + 13.2%) beat consensus on revenue and EBITDA, but below-expected audience growth.

    Taxi Lyft (LYFT: + 4.8%) posted better-than-expected quarterly revenue. The company said it was able to go into profit in the third quarter.

    General Motors (GM: -2.1%) operating income was above market expectations. At the same time, as expected by analysts, the company warned of a shortage of semiconductors.

    Dating services developer Match (MTCH: + 7.7%) acquires South Korean company Hyperconnect for $ 1.7 billion.

    Today, world stock exchanges are showing mostly positive dynamics. The news background remains calm. Ultra-soft monetary and stimulating fiscal policies remain strong factors supporting optimism. Fed Chairman Jerome Powell, during his speech in New York yesterday, reaffirmed his commitment to the course at low rates and also noted that the opening of the economy will lead to a significant increase in consumer spending. However, inflationary pressure, according to Powell, may turn out to be unstable, namely, further parameters of the monetary policy will depend on inflation and unemployment.

    Technical picture

    Technically, the S&P 500 is still in a medium-term uptrend. The trading session the day before did not change the overall picture. The broad market index is consolidating in a tight range after rising 4% last week. Resistance at the upper border of the uptrend is still a significant obstacle.

    Today Top Movers

    RCM Technologies Inc (RCMT) stock ascended 126.28% at $8.35 in the pre-market trading today.‎ The company provided an update on its recently obtained projects to assist its clients in producing higher grades of ethanol for use in beverage and hygienic applications such as sanitizer-grade ethanol. ‎

    Microvision Inc (MVIS) gained over 38.29% at $19.36 in pre-market ‎trading on Thursday after declaring that it has received necessary components and equipment to meet its April milestone of completing A-Samples of its Long-Range Lidar Sensor. ‎

    Sonos Inc (SONO) grew over 15.59% at $36.41 in pre-market trading ‎today.‎ The maker of smart speakers generated revenue of $645.6 million in its fiscal first quarter, up from $562.1 a year earlier and ahead of the $590 million that analysts surveyed by FactSet had been projecting.

    Top Upgrades & Downgrades

    Wells Fargo turned bullish on The Western Union Company (WU), upgrading the stock to “Equal-Weight” and assigning a $25.0 price target, representing potential upside of 6.43% from Wednesday’s close. 

    Pacific Biosciences of California Inc. (PACB) has won the favor of Piper Sandler’s equity research team. The firm upgraded the shares from Neutral to Overweight and moved their price target to $52.0, suggesting a 13.29% additional upside for the stock. 

    AnaptysBio Inc. (ANAB) received an upgrade from analysts at JP Morgan, who also set their one-year price target on the stock to $40.0. They changed their rating on ANAB to Overweight from Underweight in a recently issued research note.

    Earlier Thursday Piper Sandler reduced its rating on Helmerich & Payne Inc. (HP) stock to Neutral from Overweight and assigned the price target to $24. 

    Vertical Research analysts reduced their investment ratings, saying in research reports covered by the media that it’s rating for Spirit Airlines Inc. (SAVE) has been changed to Hold from Buy. 

    Analysts at Barclays downgraded Equitrans Midstream Corporation (ETRN)’s stock to Underweight from Equal-Weight Thursday.

    Latest Insider Activity

    Tesla Inc. (TSLA) Director Musk Kimbal announced the sale of shares taking place on Feb 09 at $852.12 for some 30,000 shares. The total came to more than $25.56 million. 

    The Walt Disney Company (DIS) Executive Chairman IGER ROBERT A sold on Feb 08 a total of 1,177,989 shares at $190.12 on average. The insider’s sale generated proceeds of almost $41.83 million. 

    InspireMD Inc. (NSPR) Director Kester Thomas J declared the purchase of shares taking place on Feb 08 at $0.62 for some 120,960 shares. The transaction amount was around $74995. 

    Penn National Gaming Inc. (PENN) Director SCACCETTI JANE bought on Feb 08 a total 41,978 shares at $120.99 on average. The purchase cost the insider an estimated $99,212.

    Important Earnings

    Top US earnings releases scheduled for today include Expedia Group Inc. (NASDAQ: EXPE). It will announce its Dec 2020 financial results. The company is expected to report earnings of -1.97 per share from revenues of $1.12B in the three-month period. 

    Analysts expect Kellogg Company (NYSE: K) to report a net income (adjusted) of $0.89 per share when the company releases its quarterly results shortly. Revenue for the fiscal quarter ended Dec 2020 is predicted to come in at $3.5B. 

    Tyson Foods Inc. (TSN), due to announce earnings after the market closes today, is expected to report earnings of 1.49 per share from revenues of $10.84B recently concluded three-month period.

  • Market Movers: What changed for these 21 stocks while you were sleeping

    Market Movers: What changed for these 21 stocks while you were sleeping

    ‎Greenpro Capital Corp. (GRNQ), a Conglomerates company, dropped about -‎‎5.88% ‎at $1.76 in pre-market trading Tuesday after announcing Bitcoin fund.‎

    ‎ATIF Holdings Limited (ATIF) stock plunged -8.51% to $0.9698 in the pre-‎market ‎trading.‎

    ‎Bionano Genomics Inc. (BNGO) stock soared 8.57% to $0.96 in the pre-‎market ‎trading after declaring that Praxis Genomics, LLC received accreditation from the College of ‎American ‎Pathologists (CAP). The most recent rating by Ladenburg Thalmann, on September 24, 2020, ‎is a Buy. ‎

    ‎Zomedica Corp. (AMEX: ZOM) shares are trading up 4.5% at $0.2625 at the ‎time ‎of ‎writing. Company’s 52-week ranged between $0.06 to $0.50.‎

    ‎Nano Dimension Ltd. (NASDAQ: NNDM) shares are trading up 5.52% at $8.6 at ‎the ‎time of writing after pricing $250 million registered direct offering. ‎Company’s 52-week ‎ranged ‎between $0.51 to $10.49. Analysts have a consensus price target of $8. ‎

    ‎Jaguar Health Inc. (JAGX) stock moved down -2.88 percent to $0.7325 in the pre-‎‎market trading.‎

    ‎Ideanomics Inc. (IDEX), a Software – Application company, rose about 4.27% at ‎‎$2.44 ‎in pre-market trading Tuesday following the declaration the signing of an agreement of its ‎Mobile ‎Energy Global (“MEG”) and contracting entity Qingdao Chengyang Medici with Meihao ‎Chuxing, a joint ‎venture between BYD and Didi, to purchase an initial 2,000 units of model BYD D1. ‎

    ‎Alibaba Group Holding Limited (BABA) is up more than 3.64% at $230.45 in pre-‎‎‎market hours Tuesday December 29, 2020. The stock had jumped over 0.16% to $222.36 in ‎the ‎last ‎trading session.‎

    Before the trading started on December 29, 2020, FuelCell Energy Inc. (FCEL) is ‎up ‎‎2.3% to reach $11.81. It has been trading in a 52-week range of $0.84 to $13.91.‎

    ‎AeroCentury Corp. (ACY) lost over -25.7% at $10.29 in pre-market trading ‎Tuesday ‎December 29, 2020 following the update of listing standards compliance.‎

    ‎Color Star Technology Co. Ltd. (CSCW) is down more than -9.21% at $0.69 in pre-‎‎‎market hours Tuesday December 29, 2020. The stock had jumped over 7.04% to $0.76 in ‎the ‎last ‎trading session.‎

    Before the trading started on December 29, 2020, Guardion Health Sciences ‎Inc. ‎‎(GHSI) is up 14.83% to reach $0.36. The firm recently reported the appointment of ‎Bret ‎Scholtes, as its President and Chief Executive Officer, and as a member of the Board of Directors. ‎He is ‎a veteran of the nutritional products industry for nearly a decade. It has been trading in a 52-‎week ‎range of $0.17 to $0.74.‎

    ‎Nokia Corporation (NOK) stock soared 2.31% to $3.99 in the pre-market ‎trading ‎after reporting that it has been selected by Thailand’s dtac as its first 5G partner.‎ The most ‎recent ‎rating by Exane BNP Paribas, on October 30, 2020, is a Neutral. ‎

    Before the trading started on December 29, 2020, Acasti Pharma Inc. (ACST) is ‎up ‎‎7.32% to reach $0.3343. It has been trading in a 52-week range of $0.17 to $2.75.‎

    ‎RMG Acquisition Corp. (RMG) grew over 2.1% at $32.61 in pre-market trading ‎today ‎following the stockholder approval of business combination with Romeo Systems, Inc. with ‎no ‎redemptions.‎

    ‎Aprea Therapeutics Inc. (APRE), a Biotechnology company, rose about 4.73% ‎at ‎‎$5.76 in pre-market trading Tuesday after declaring results of primary endpoint from Phase 3 trial ‎of ‎Eprenetapopt in TP53 Mutant Myelodysplastic Syndromes (MDS).‎

    ‎MicroVision Inc. (NASDAQ: MVIS) shares are trading up 6.41% at $7.14 at ‎the ‎time ‎of writing. Company’s 52-week ranged between $0.15 to $9.74. Analysts have a consensus ‎price ‎target ‎of $4.50.‎

    ‎China Recycling Energy Corporation (CREG) is down more than -2.23% at $5.7 in pre-‎‎market hours Tuesday December 29, 2020 after revealing that it has entered into agreement to ‎acquire ‎Xi’an Taiying Energy Saving Technology ‎Co., Ltd..‎. The stock had jumped over 31.31% to $5.83 in ‎the last ‎trading session. ‎

    ‎BIOLASE Inc. (BIOL) stock moved up 25.44 percent to $0.6021 in the pre-‎market ‎trading.‎

    ‎Borr Drilling Limited (BORR), a Oil & Gas Drilling company, rose about 4.66% ‎at ‎‎$0.854 in pre-market trading Tuesday after reporting the appointment of Mr. Magnus Vaaler as its ‎new ‎Chief Financial Officer. He will replace Mr. Christoph Bausch.‎

    ‎Onconova Therapeutics Inc. (NASDAQ: ONTX) shares are trading up 3.68% ‎at ‎‎$0.465 ‎at the time of writing. Company’s 52-week ranged between $0.19 to $1.56. Analysts have ‎a ‎consensus ‎price target of $7.50.‎

  • 15 Trending Stocks To Watch In Diagnostics And Research Industry

    15 Trending Stocks To Watch In Diagnostics And Research Industry

    The Diagnostic Research Industry is playing an integral part in the medical evaluation and treatment of patients.  This industry is vital to the healthcare market as it is providing information related to the severity and causes of illnesses in patients to healthcare practitioners. The changes we are witnessing in today’s healthcare industry are setting the goal for evolution we will see over the next decade.

    There are major drivers that are changing and will change the direction of this industry in present and future as well. The first driver is technology. As time passes by, new technologies are emerging and playing a very important role in the healthcare industry. In today’s world, patients want easier access to care and demand better service. The demand for this industry is linked to the number of patients receiving the treatment. The profitability and growth of the company depend on good marketing and efficient operations.

    Let check these 15 companies in Diagnostic Research Industry to know more about this industry and the trends this industry is following:

    Interpace Biosciences Inc. (NASDAQ: IDXG)

    Interpace Biosciences Inc. (NASDAQ: IDXG) shares were trading up 32.89% at $3.96 at the time of writing on Wednesday. Interpace Biosciences Inc. (NASDAQ: IDXG) share price went from a low point around $2.57 to briefly over $11.00 in the past 52 weeks, though shares have since pulled back to $3.96. IDXG market cap has remained high, hitting $15.88M at the time of writing, giving it a price-to-sales ratio of more than 0.

    Interpace Biosciences Inc. (NASDAQ: IDXG) has announced that the Audit Committee has disclosed the result of an independent investigation. The committee has completed the investigation with the statement that the allegations made in the complaints were unverified and there is no truth behind them. investigation and If we look at the recent analyst rating IDXG, Janney initiated coverage on IDXG shares with a Buy rating.

    OPKO Health Inc. (NASDAQ: OPK)

    OPKO Health Inc. (NASDAQ: OPK) last closed at $4.07, in a 52-week range of $1.12 to $6.47. Analysts have a consensus price target of $8.00. OPKO Health Inc. (OPK) disclosed it plans to report operating and financial results for the three months ended September 30, 2020, as well as discuss financial guidance, after the close of the U.S. financial markets on Thursday, October 29, 2020.

    Invitae Corporation (NYSE: NVTA)

    Invitae Corporation (NYSE: NVTA) stock drop by -6.29% to $49.28. The most recent rating by JP Morgan, on October 14, 2020, is at a Neutral. Invitae Corporation (NVTA) disclosed that on October 2, 2020, it has executed the transaction to bring ArcherDX into Invitae to create a comprehensive offering that provides testing services for disease risk, therapy optimization, and personalized cancer monitoring to enable precision approaches to cancer treatment.

    Pacific Biosciences of California Inc. (NASDAQ: PACB)

    Pacific Biosciences of California Inc. (NASDAQ: PACB) shares headed rising, higher as much as 0.07%. The most recent rating by JP Morgan, on October 02, 2020, is at an Overweight. Pacific Biosciences of California Inc. (PACB) has disclosed that collaborated with Children’s Mercy Kansas City to further understand the most challenging pediatric diseases. The companies will join forces to sequence a statistically significant cohort of rare disease cases for which previous whole-genome and whole-exome sequencing studies yielded no answers.

    Bionano Genomics Inc. (NASDAQ: BNGO)

    Bionano Genomics Inc. (NASDAQ: BNGO) fall -0.15% after losing more than $0.0 on Wednesday. Bionano Genomics Inc. (BNGO) revealed today that it is scheduled to release financial results of the third quarter ended September  30, 2020, on November 12, 2020. The company will also hold the conference call on the same day.

    T2 Biosystems Inc. (NASDAQ: TTOO)

    T2 Biosystems Inc. (NASDAQ: TTOO) stock drop by 0.00% to $1.33 after T2 Biosystems to Report Third Quarter 2020 Financial Results on November 4, 2020. The most recent rating by BTIG Research, on October 08, 2020, is at a Buy.  T2 Biosystems Inc. (TTOO) market capitalization has remained high, hitting $196.79 million at the time of writing.

    NeoGenomics Inc. (NASDAQ: NEO)

    NeoGenomics Inc. (NASDAQ: NEO) Shares headed rising, higher as much as 5.46%. The most recent rating by Morgan Stanley, on September 09, 2020, is at an Overweight. NeoGenomics Inc. (NEO) revealed its plans to open a state-of-the-art research laboratory in China in association with the new lab PPD, Inc. (NASDAQ: PPD) is opening in Suzhou.

    PerkinElmer Inc. (NYSE: PKI)

    PerkinElmer Inc. (NYSE: PKI) fall -2.10% after losing more than -$2.62 on Wednesday. PerkinElmer Inc. (PKI) earlier announced that it is expected to report organic revenue growth of approximately 35% and 33%, respectively, for the third quarter ended October 4, 2020.

    Chembio Diagnostics Inc. (NASDAQ: CEMI)

    Chembio Diagnostics Inc. (NASDAQ: CEMI) last closed at $4.77, in a 52-week range of $2.25 to $15.89. Analysts have a consensus price target of $5.00. Chembio Diagnostics Inc. (CEMI) disclosed earlier that the U.S. Food and Drug Administration (FDA) has approved the Premarket Approval (PMA) application for the DPP HIV-Syphilis System.

    Illumina Inc. (NASDAQ: ILMN)

    Illumina Inc. (NASDAQ: ILMN) Shares headed falling, lower as much as -4.35%. The most recent rating by Guggenheim, on October 13, 2020, is at a Neutral. Illumina Inc. (ILMN) has earlier announced that it is scheduled to release the third quarter 2020 following the close of the market on Thursday, October 29, 2020.

    Enzo Biochem Inc. (NYSE: ENZ)

    Enzo Biochem Inc. (NYSE: ENZ) fall -17.24% after losing more than -$0.45 on Wednesday. Enzo Biochem Inc. (ENZ) earlier reported financial results for the fourth quarter and full-year ended July 31, 2020, and provided a business update on recent corporate and operational developments.

    Fulgent Genetics Inc. (NASDAQ: FLGT)

    Fulgent Genetics Inc. (NASDAQ: FLGT) last closed at $38.17, in a 52-week range of $6.70 to $52.47. Analysts have a consensus price target of $56.25. Fulgent Genetics Inc. (FLGT) disclosed earlier that the Ohio Department of Rehabilitation and Correction (“ODRC”) has selected Fulgent Genetics for their COVID-19 testing needs.

    QIAGEN N.V. (NYSE: QGEN)

    QIAGEN N.V. (NYSE: QGEN) stock drop by -0.11% to $52.37. The most recent rating by BofA Securities, on October 06, 2020, is at a Buy. QIAGEN N.V. (QGEN) earlier announced preliminary sales and adjusted earnings per share (EPS) results for the third quarter of 2020. It has shared that the Net sales grew 26% at actual rates, and also rose 26% at constant exchange rates (CER) $481.3 million from $382.7 million in the same period of 2019.

    Fluidigm Corporation (NASDAQ: FLDM)

    Fluidigm Corporation (NASDAQ: FLDM) last closed at $6.89, in a 52-week range of $1.17 to $12.45. Fluidigm Corporation (FLDM) has moved up 488.03% from its 52-weeks low and moved down -44.74% from its 52-weeks high. Looking at its liquidity, it has a current ratio of $509.65 million at the time of writing.

    Danaher Corporation (NYSE: DHR)

    Danaher Corporation (NYSE: DHR) stock soar by 0.41% to $226.55. The most recent rating by Wolfe Research, on June 16, 2020, is at an Outperform. Danaher Corporation (DHR) share price went from a low point around $119.60 to briefly over $227.48 in the past 52 weeks, though shares have since pulled back to $222.59. DHR  market cap has remained high, hitting $156.91 billion at the time of writing.

     

     

  • 10 Of The Best Diagnostics Research Industry Stocks To Buy For 2020

    10 Of The Best Diagnostics Research Industry Stocks To Buy For 2020

    Healthcare is a dynamic and opportunity-rich industry. The demand for innovations that brings improvement in health outcomes, affordability, quality, and access will continue to be high. The changes we witnessed in the healthcare industry today have set a new tone for the change in the coming few years. 2020 is the year of change for the health care industry.

    The first thing which played an important role in the healthcare industry is Technology. Technology is continuously changing and brings new improvement in the healthcare industry. Patients today want easier and affordable access to care and better demand services. In this changing environment, diagnostics is emerging as a key driver in helping to address these needs.

    Here are the top 10 leading companies in Diagnostics Research Industry that need your attention:

    OPKO Health Inc. (NASDAQ: OPK)

    OPKO Health Inc. (NASDAQ: OPK) shares were trading down -0.92% at $3.22 at the time of writing on Tuesday. OPKO Health Inc. (NASDAQ: OPK) share price went from a low point around $1.12 to briefly over $6.47 in the past 52 weeks, though shares have since pulled back to $3.22. OPK market cap has remained high, hitting $2.13B at the time of writing, giving it a price-to-sales ratio of more than 2.

    OPKO Health Inc. has earlier started a Phase 2 trial with RAYALDEE as a treatment for mild-to-moderate COVID-19.  If we look at the recent analyst rating OPK, Piper Jaffray initiated coverage on OPK shares with an Overweight rating.

    Pacific Biosciences of California Inc. (NASDAQ: PACB)

    Pacific Biosciences of California Inc. (NASDAQ: PACB) last closed at $8.78, in a 52-week range of $2.20 to $8.38. Analysts have a consensus price target of $6.50. Pacific Biosciences of California Inc. (PACB) has announced it has appointed Susan G. Kim as Chief Financial Officer. The decision is effective as of September 28, 2020. Susan has joined the company at a time when there are various growth opportunities for the company.

    Bionano Genomics Inc. (NASDAQ: BNGO)

    Bionano Genomics Inc. (NASDAQ: BNGO) stock soar by 0.79% to $0.64. The most recent rating by Oppenheimer, on April 08, 2020, is at an Outperform. Bionano Genomics Inc. (BNGO) will participate in the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit. the summit is scheduled to take place virtually on September 21-23, 2020. This company market capitalization has remained high, hitting $90.45 million at the time of writing.

    Illumina Inc. (NASDAQ: ILMN)

    Illumina Inc. (NASDAQ: ILMN) shares headed falling, lower as much as -0.60%. The most recent rating by UBS, on September 22, 2020, is at a Neutral. Illumina Inc. (ILMN) has officially revealed an agreement to buy cancer-testing company Grail for about $8 billion in cash and stock. This company market capitalization has remained high, hitting $39.54 billion at the time of writing.

    Precipio Inc. (NASDAQ: PRPO)

    Precipio Inc. (NASDAQ: PRPO) shares headed rising, higher as much as 2.63%. Precipio Inc. has revealed that it has introduced its HemeScreen AML (Acute Myeloid Leukemia) panel both clinically in its CLIA laboratory, and as part of its HemeScreen product offering. This company market capitalization has remained high, hitting 37.42 million at the time of writing.

    Fulgent Genetics Inc. (NASDAQ: FLGT)

    Fulgent Genetics Inc. (NASDAQ: FLGT) stock soar by 7.08% to $40.25. The most recent rating by Oppenheimer, on August 20, 2020, is at an Outperform. Fulgent Genetics Inc. (FLGT) will replace Garrett Motion Inc. (GTX) in the S&P SmallCap 600 effective before the opening of trading on Friday, September 25. This company’s market capitalization has remained high, hitting $821.10 million at the time of writing.

    Fluidigm Corporation (NASDAQ: FLDM)

    Fluidigm Corporation (NASDAQ: FLDM) fall -1.29% after losing more than -$0.11 on Tuesday. In the past 52-weeks of trading, this company’s stock fluctuated between the low range of $1.17 and a high range of $12.45. It has moved up 595.73% from its 52-weeks low and moved down -34.62% from its 52-weeks high. Looking at its liquidity it has a current ratio of 2.00. This company’s market capitalization has remained high, hitting $523.91 million at the time of writing.

    Invitae Corporation (NYSE: NVTA)

    Invitae Corporation (NYSE: NVTA) last closed at $43.10, in a 52-week range of $7.41 to $40.96. Analysts have a consensus price target of $36.25. Invitae Corporation (NVTA) has moved up 475.19% from its 52-weeks low and moved down -2.16% from its 52-weeks high. Looking at its liquidity it has a current ratio of 3.70. This company’s market capitalization has remained high, hitting $5.56 billion at the time of writing.

    HTG Molecular Diagnostics Inc. (NASDAQ: HTGM)

    HTG Molecular Diagnostics Inc. (NASDAQ: HTGM) fall -8.01% after losing more than -$0.03 on Tuesday. HTG Molecular Diagnostics Inc. (HTGM) share price went from a low point around $0.27 to briefly over $0.99 in the past 52 weeks, though shares have since pulled back to $0.32. HTG Molecular Diagnostics Inc. market cap has remained high, hitting $22.70 million at the time of writing

    Co-Diagnostics Inc. (NASDAQ: CODX)

    Co-Diagnostics Inc. (NASDAQ: CODX) last closed at $14.93, in a 52-week range of $0.85 to $30.99. Co-Diagnostics Inc. (CODX) has moved up 1567.08% from its 52-weeks low and moved down -54.47% from its 52-weeks high. Looking at its liquidity it has a current ratio of 11.60. This company’s market capitalization has remained high, hitting $404.90 million at the time of writing.